Publications

Rutkovskis E, Ravagli E, Lancashire HT, Shah Idil A, Thompson N, Perkins JD, Challita R, Hadaya J, Vivekananda U, Ajijola O, Shivkumar K, Miserocchi A,[...]

By afschroeder • September 15, 2026

Suruga K, Patel V, Shitan H, Yuchao G, Nagasaka T, Ng D, Menda J, Singh A, Goyal A, Buss E, Kremenovic A, Dermand E, Jain[...]

By afschroeder • September 15, 2026

Distler JHW, Assassi S, Gabrielli A, Allanore Y, Chung L, Cutolo M, Galdo FD, De Vries-Bouwstra JK, Domsic RT, Elhai M, Frech T, Hinchcliff M,[...]

By afschroeder • September 15, 2026

Smart K, Armstrong AW, Adler BL. Letter: Patch Test Utilization by Provider Type in the U.S. Commercially Insured Population, 2014-2024: Dermatologists on the Decline. Dermatitis. 2026 Sep[...]

By afschroeder • September 15, 2026

Deng M, Brewer GM, Espinoza A, Orellana-Montes J, Hedayatyanfard K, Hu C, Jahan MGS, Deriss M, Davis JC, Cheng CE, Pellegrini M, Agak GW. Xenium[...]

By afschroeder • September 14, 2026

Wu YL, Majem M, John T, Grohé C, Wang J, Goldman JW, Lu S, Shepherd FA, Wang Q, Kato T, Aokage K, Zhong WZ, Laktionov[...]

By afschroeder • September 14, 2026

Moore JP, Paul T, Etheridge SP. The latest Fontan paradox: when less is more (difficult). Europace. 2026 Sep 2;28(9):euag239. doi: 10.1093/europace/euag239. PMID: 42732894; PMCID: PMC13571844.

By afschroeder • September 14, 2026

Paniker AG, Marshalek JP, Chao E, Yashar D, Tomassetti S. Management Patterns and Outcomes for Relapsed or Refractory Hodgkin Lymphoma. J Hematol. 2026 Aug 31;15(4):188-197.[...]

By afschroeder • September 13, 2026

Tatsuno Y, Sarkisian CA, Mafi JN, Kitajima K, Sato D, Tsugawa Y, Miyawaki A. Primary care physician characteristics and potentially inappropriate medications in older adults.[...]

By afschroeder • September 13, 2026

Msaouel P, La Rosa S, Abel EJ, Albiges L, Barata PC, Berg SA, Braun DA, Brugarolas J, Campbell MT, Carlo MI, Coleman K, Cost NG,[...]

By afschroeder • September 13, 2026